drugset

drugset / Trial / NCT01761565

Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

NCT01761565 ↗

Phase 1 Completed 40 enrolled Talphera, Inc

Non-randomizedSingle-groupOpen-labelBasic science

Summary

Determine the plasma concentration profile after single and multiple dosing of Sufentanil NanoTabs

Timeline

Start: 2013-01
Primary completion: 2013-02
Completion: 2013-02

Publications

Background Willsie SK, Evashenk MA, Hamel LG, Hwang SS, Chiang YK, Palmer PP. Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers. Clin Ther. 2015 Jan 1;37(1):145-55. doi: 10.1016/j.clinthera.2014.11.001. Epub 2014 Dec 24.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sufentanil	Other / unclassified	15 ug	—

Indications

No indication recorded.